BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yin H, Wang X, Zhang X, Zeng Y, Xu Q, Wang W, Zhou F, Zhou Y. UBE2T promotes radiation resistance in non-small cell lung cancer via inducing epithelial-mesenchymal transition and the ubiquitination-mediated FOXO1 degradation. Cancer Lett 2020;494:121-31. [PMID: 32590022 DOI: 10.1016/j.canlet.2020.06.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Tan B, Zhang J, Wang W, Ma H, Yang Y, Sopper S. E3 Ubiquitin Ligase CHIP Inhibits the Interaction between Hsp90β and MAST1 to Repress Radiation Resistance in Non-Small-Cell Lung Cancer Stem Cells. Stem Cells International 2022;2022:1-13. [DOI: 10.1155/2022/2760899] [Reference Citation Analysis]
2 Xiao L, Huang Y, Li Q, Wang S, Ma L, Fan Z, Tang Z, Yuan X, Liu B. Identification of a prognostic classifier based on EMT-related lncRNAs and the function of LINC01138 in tumor progression for lung adenocarcinoma. Front Mol Biosci 2022;9:976878. [DOI: 10.3389/fmolb.2022.976878] [Reference Citation Analysis]
3 Yang H, Wang Z, Gong L, Huang G, Chen D, Li X, Du F, Lin J, Yang X, Nikseresht M. A Novel Hypoxia-Related Gene Signature with Strong Predicting Ability in Non-Small-Cell Lung Cancer Identified by Comprehensive Profiling. International Journal of Genomics 2022;2022:1-18. [DOI: 10.1155/2022/8594658] [Reference Citation Analysis]
4 Li Y, Yang X, Lu D. Knockdown of ubiquitin-conjugating enzyme E2T (UBE2T) suppresses lung adenocarcinoma progression via targeting fibulin-5 (FBLN5). Bioengineered 2022;13:11867-80. [PMID: 35543375 DOI: 10.1080/21655979.2022.2060162] [Reference Citation Analysis]
5 Wang Z, Chen N, Liu C, Cao G, Ji Y, Yang W, Jiang Q. UBE2T is a prognostic biomarker and correlated with Th2 cell infiltrates in retinoblastoma. Biochem Biophys Res Commun 2022;614:138-44. [PMID: 35594577 DOI: 10.1016/j.bbrc.2022.04.096] [Reference Citation Analysis]
6 Manunu B, Serafin AM, Akudugu JM. BAG1, MGMT, FOXO1, and DNAJA1 as potential drug targets for radiosensitizing cancer cell lines. Int J Radiat Biol 2022;:1-52. [PMID: 35511481 DOI: 10.1080/09553002.2022.2074164] [Reference Citation Analysis]
7 Li H, Liu L, Chen HY, Yan X, Li RL, Lan J, Xue KY, Li X, Zhuo CL, Lin L, Li LY, Wu Z, Zhang D, Wang XM, Huang WJ, Wang Y, Jiang W, Zhou L. Mogrol suppresses lung cancer cell growth by activating AMPK-dependent autophagic death and inducing p53-dependent cell cycle arrest and apoptosis. Toxicol Appl Pharmacol 2022;:116037. [PMID: 35489526 DOI: 10.1016/j.taap.2022.116037] [Reference Citation Analysis]
8 Zheng Y, Han X, Wang T. Role of H2A.Z.1 in epithelial-mesenchymal transition and radiation resistance of lung adenocarcinoma in vitro. Biochem Biophys Res Commun 2022;611:118-25. [PMID: 35525100 DOI: 10.1016/j.bbrc.2022.03.141] [Reference Citation Analysis]
9 Huang W, Huang H, Xiao Y, Wang L, Zhang T, Fang X, Xia X. UBE2T is upregulated, predicts poor prognosis, and promotes cell proliferation and invasion by promoting epithelial-mesenchymal transition via inhibiting autophagy in an AKT/mTOR dependent manner in ovarian cancer. Cell Cycle 2022;:1-12. [PMID: 35130130 DOI: 10.1080/15384101.2022.2031426] [Reference Citation Analysis]
10 Wei K, Ma Z, Yang F, Zhao X, Jiang W, Pan C, Li Z, Pan X, He Z, Xu J, Wu W, Xia Y, Chen L. M2 macrophage-derived exosomes promote lung adenocarcinoma progression by delivering miR-942. Cancer Lett 2022;526:205-16. [PMID: 34838826 DOI: 10.1016/j.canlet.2021.10.045] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
11 Chen F, Li M, Wang L. LncRNA CASC11 Promotes Hepatocellular Carcinoma Progression via Upregulation of UBE2T in a m6A-Dependent Manner. Front Oncol 2021;11:772671. [PMID: 34900723 DOI: 10.3389/fonc.2021.772671] [Reference Citation Analysis]
12 Chen Y, Hong H, Wang Q, Li J, Zhang W, Chen T, Li P. NEDD4L-induced ubiquitination mediating UBE2T degradation inhibits progression of lung adenocarcinoma via PI3K-AKT signaling. Cancer Cell Int 2021;21:631. [PMID: 34838005 DOI: 10.1186/s12935-021-02341-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Liu Y, Ji W, Yue N, Zhou W. Ubiquitin-conjugating enzyme E2T promotes tumor stem cell characteristics and migration of cervical cancer cells by regulating the GRP78/FAK pathway. Open Life Sci 2021;16:1082-90. [PMID: 34703898 DOI: 10.1515/biol-2021-0108] [Reference Citation Analysis]
14 Yin H, Chen L, Piao S, Wang Y, Li Z, Lin Y, Tang X, Zhang H, Zhang H, Wang X. M6A RNA methylation-mediated RMRP stability renders proliferation and progression of non-small cell lung cancer through regulating TGFBR1/SMAD2/SMAD3 pathway. Cell Death Differ 2021. [PMID: 34628486 DOI: 10.1038/s41418-021-00888-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
15 Li L, Liu J, Huang W. E2F5 promotes proliferation and invasion of gastric cancer through directly upregulating UBE2T transcription. Dig Liver Dis 2021:S1590-8658(21)00772-6. [PMID: 34583905 DOI: 10.1016/j.dld.2021.09.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 Zhu J, Ao H, Liu M, Cao K, Ma J. UBE2T promotes autophagy via the p53/AMPK/mTOR signaling pathway in lung adenocarcinoma. J Transl Med 2021;19:374. [PMID: 34461934 DOI: 10.1186/s12967-021-03056-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
17 Wang L, Tang L, Xu R, Ma J, Tian K, Liu Y, Lu Y, Wu Z, Zhu X. DEPDC1B regulates the progression of human chordoma through UBE2T-mediated ubiquitination of BIRC5. Cell Death Dis 2021;12:753. [PMID: 34330893 DOI: 10.1038/s41419-021-04026-7] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
18 Guo D, Jin J, Liu J, Dong X, Li D, He Y. MicroRNA-29b regulates the radiosensitivity of esophageal squamous cell carcinoma by regulating the BTG2-mediated cell cycle. Strahlenther Onkol 2021;197:829-35. [PMID: 34232332 DOI: 10.1007/s00066-021-01790-5] [Reference Citation Analysis]
19 Ren X, Li A, Ying E, Fang J, Li M, Yu J. Upregulation of ubiquitin-conjugating enzyme E2T (UBE2T) predicts poor prognosis and promotes hepatocellular carcinoma progression. Bioengineered 2021;12:1530-42. [PMID: 33934686 DOI: 10.1080/21655979.2021.1918507] [Reference Citation Analysis]
20 Tian T, Fu X, Hu L, Yang X, Sun P, Sun F. FAST1 Predicts Poor Survival of Renal Carcinoma and Promotes Its Progression Through the TGF-β/Smad Pathway. Onco Targets Ther 2021;14:1487-99. [PMID: 33679133 DOI: 10.2147/OTT.S288847] [Reference Citation Analysis]
21 Qiao L, Dong C, Ma B. UBE2T promotes proliferation, invasion and glycolysis of breast cancer cells by regualting the PI3K/AKT signaling pathway. J Recept Signal Transduct Res 2021;:1-9. [PMID: 33435787 DOI: 10.1080/10799893.2020.1870495] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Zhang D, Liu J, Xie T, Jiang Q, Ding L, Zhu J, Ye Q. Oleate acid-stimulated HMMR expression by CEBPα is associated with nonalcoholic steatohepatitis and hepatocellular carcinoma. Int J Biol Sci 2020;16:2812-27. [PMID: 33061798 DOI: 10.7150/ijbs.49785] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]